[ Price : $8.95]
Federal Register notice: FDA announces its fiscal year 2025 CDER Office of Pharmaceutical Quality Experiential Learning Site Visit...[ Price : $8.95]
FDA gives accelerated approval to Novartis Fabhalta for reducing proteinuria in primary IgA nephropathy.[ Price : $8.95]
FDA clears a Huxley Medical 510(k) for at-home sleep apnea diagnostic patch, Sansa.[ Price : $8.95]
Federal Register notice: FDA announces a 9/9 Antimicrobial Drugs Advisory Committee meeting to discuss an Iterum Therapeutics NDA ...[ Price : $8.95]
Federal Register notice: FDA reopens the comment period for its proposed administrative order entitled Amending Over-the-Counter M...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion releases plans to survey 2,400 healthcare providers on several issues relating to p...[ Price : $8.95]
FDA approves a Servier Pharmaceuticals NDA for Voranigo (vorasidenib) for treating certain adult and pediatric patients 12 years a...[ Price : $8.95]
CDER compliance officer Yasamin Ameri says FDA will issue about the same number of drug CGMP Warning Letters in 2024 as in 2023.